Voglibose and Metformin SR 0.2mg"'"

Voglibose and Metformin SR (sustained-release)
VOGLIGOLD M  are often prescribed together as a combination therapy for the management of type 2 diabetes mellitus. Each of these medications works through different mechanisms to help control blood sugar levels, and their combination can provide complementary benefits.
Voglibose:
Voglibose is an alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the digestive tract. This helps prevent rapid spikes in blood sugar levels after meals. By inhibiting the alpha-glucosidase enzyme, voglibose reduces the breakdown of complex carbohydrates into simple sugars, delaying their absorption into the bloodstream.
Metformin SR (Sustained-Release):
Metformin is a biguanide medication that improves the body's sensitivity to insulin, reduces glucose production in the liver, and decreases the absorption of glucose from the intestines. Metformin SR is a sustained-release formulation, which means it releases the medication slowly over an extended period, allowing for once-daily dosing and potentially reducing gastrointestinal side effects compared to immediate-release formulations.
When VOGLIGOLD M are combined, their mechanisms of action complement each other to achieve better blood sugar control throughout the day. Voglibose helps manage post-meal glucose spikes, while Metformin SR addresses fasting and overall glucose levels.
For further information please contact:
info@sterispharma.com
Order Now - https://www.sterisonline.com/product/vogligold-m-0-2-134182